| Literature DB >> 31506092 |
Wen-Bin Zheng1,2, Yang Zou2, Hany M Elsheikha3, Guo-Hua Liu1, Min-Hua Hu4, Shui-Lian Wang5, Xing-Quan Zhu6,7.
Abstract
BACKGROUND: Toxocara canis, a globally distributed roundworm, can cause debilitating disease in dogs and humans; however, little is known about the metabolomic response of the hosts to T. canis infection. There is an increasing need to understand the metabolic mechanisms underlying the pathogenesis of T. canis infection in dogs. Here, we examined the metabolomic changes in Beagle dogs' serum following T. canis infection using LC-MS/MS.Entities:
Keywords: Beagle dog; LC-MS/MS; Metabolomic; Serum; Toxocara canis; Toxocariasis
Mesh:
Substances:
Year: 2019 PMID: 31506092 PMCID: PMC6737696 DOI: 10.1186/s13071-019-3703-5
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 3.876
Summary of the differential ions at different infection stages
| Group | Number | Ion mode | Difference in ion number | Upa | Upa (MS) | Upa (MS2) | Downa | Downa (MS) | Downa (MS2) | MS | MS2 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A12hT | 7 | ESI(+) | 59 | 31 | 19 | 10 | 28 | 19 | 9 | 38 | 19 |
| ESI(−) | 81 | 37 | 22 | 8 | 44 | 23 | 9 | 45 | 17 | ||
| B24hT | 6 | ESI(+) | 417 | 330 | 191 | 145 | 87 | 55 | 30 | 246 | 175 |
| ESI(−) | 91 | 34 | 17 | 11 | 57 | 19 | 12 | 36 | 23 | ||
| D10dT | 7 | ESI(+) | 500 | 137 | 91 | 55 | 363 | 265 | 181 | 356 | 236 |
| ESI(−) | 814 | 271 | 150 | 87 | 543 | 358 | 227 | 508 | 314 | ||
| F36dT | 6 | ESI(+) | 285 | 138 | 80 | 60 | 147 | 98 | 48 | 178 | 108 |
| ESI(−) | 268 | 72 | 30 | 16 | 196 | 88 | 40 | 118 | 56 |
aUp and down indicate upregulated and downregulated differential ion number, respectively
Abbreviations: MS, first mass spectrometry; MS2, secondary mass spectrometry
Fig. 1The number of eosinophils in the infected and control groups at the four indicated infection stages in the blood of Beagle dogs infected with 300 T. canis embryonated eggs were analyzed by t-test using GraphPad Prism v.5. [24 h infection group vs 10 d infection group: t(11) = 6.64, P < 0.001; 10 d infection group vs 10 d control group: t(11) = 7.67, P < 0.001; 10 d infection group vs 36 d infection group: t(11) = 4.22, P < 0.01; 36 d infection group vs 36 d control group: t(10) = 3.37, P < 0.05]. *P < 0.05, **P < 0.01, ***P < 0.001
Fig. 2Partial least squares discriminant analysis (PLS-DA) score scatter plots of ions at 10 dpi in Beagle dogs infected with 300 T. canis embryonated eggs. a PLS-DA score plots of the control group (C) and infection group (T) at 10 dpi in ESI+ mode. b PLS-DA score plots of the control group (C) and infection group (T) at 10 dpi in ESI− mode
Fig. 3Venn diagrams showing the common and unique differential ions among 24 hpi, 10 dpi and 36 dpi in ESI+ mode (a) and ESI− mode (b)
Potential biomarker metabolites of Toxocara canis infection in dog serum at 12 hpi and 24 hpi to 36 dpi by LC-MS/MS
| Infection stage | Ion mode | Metabolites | Entry | AUC | Log2(FC) | Metabolic pathways | |
|---|---|---|---|---|---|---|---|
| 12 hpi | ESI(+) | O-isovaleryl- | C20826 | 0.959 | 0.0158 | − 0.4179 | Not known |
| 12 hpi | ESI(+) | TG(i-16:0/i-16:0/13:0) | HMDB0103789 | 0.959 | 0.0056 | 0.5935 | Not known |
| 12 hpi | ESI(+) | (2E)-3-[4-(sulfooxy)phenyl]prop-2-enoic acid | HMDB0125166 | 0.939 | 0.0057 | − 1.0655 | Not known |
| 12 hpi | ESI(+) | 3’-deoxydihydrostreptomycin | C03755 | 0.939 | 0.0027 | 0.3250 | Not known |
| 12 hpi | ESI(+) | Docosahexaenoic acid | C06429 | 0.918 | 0.0142 | − 0.4043 | Biosynthesis of unsaturated fatty acids |
| 12 hpi | ESI(+) | Novapikromyin | C20740 | 0.918 | 0.0094 | 0.2805 | Not known |
| 12 hpi | ESI(−) | Calcitroic acid | C18230 | 1.000 | 0.0487 | − 0.4470 | Not known |
| 12 hpi | ESI(−) | Docosapentaenoic acid | C16513 | 0.959 | 0.0081 | − 0.4776 | Biosynthesis of unsaturated fatty acids |
| 12 hpi | ESI(−) | Monoacylglycerol | HMDB0011573 | 0.918 | 0.0086 | − 0.4091 | Not known |
| 24 hpi to 36 dpi | ESI(+) | Biotin amide | C01893 | 0.871 | 2.21E−05 | 0.8046 | Not known |
| 24 hpi to 36 dpi | ESI(+) | Iridotrial | C06070 | 0.819 | 0.0067 | 0.3800 | Biosynthesis of secondary metabolites |
| 24 hpi to 36 dpi | ESI(+) | {[1-(4-methoxyphenyl)pentan-3-yl]oxy}sulfonic acid | HMDB0133010 | 0.807 | 0.0010 | 0.4903 | Not known |
| 24 hpi to 36 dpi | ESI(−) | Angiotensin (5–8) | C20972 | 0.810 | 0.0008 | − 0.3484 | Not known |
| 24 hpi to 36 dpi | ESI(−) | L-Threonate | 0.807 | 0.0025 | 0.3041 | Ascorbate and aldarate metabolism |
Fig. 4Comparisons of differential metabolites based on multivariate ROC curve analysis. a Biomarker metabolites identified at 12 hpi. b Biomarker metabolites identified at 24 hpi, 10 dpi and 36 dpi. Var. (variables) indicates the number of selected features
Fig. 5Venn diagram showing the common and unique differential metabolic pathways among 24 hpi, 10 dpi and 36 dpi in ESI+ mode (a) and ESI− mode (b)
Fig. 6Schematic overview of the differential metabolites involved in arachidonic acid metabolites pathway at 12 hpi, 10 dpi and 36 dpi. Red and blue arrows represent upregulation and downregulation, respectively. No arrows indicate that the metabolites were not significantly different in this infection stage